Cargando…
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction
BACKGROUND: Sudden death (SD) and pump failure death (PFD) are leading modes of death in heart failure and preserved ejection fraction (HFpEF). Risk stratification for mode-specific death may aid in patient enrichment for new device trials in HFpEF. METHODS: Models were derived in 4116 patients in t...
Autores principales: | Shen, Li, Jhund, Pardeep S., Anand, Inder S., Carson, Peter E., Desai, Akshay S., Granger, Christopher B., Køber, Lars, Komajda, Michel, McKelvie, Robert S., Pfeffer, Marc A., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318942/ https://www.ncbi.nlm.nih.gov/pubmed/33301080 http://dx.doi.org/10.1007/s00392-020-01786-8 |
Ejemplares similares
-
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
por: Shen, Li, et al.
Publicado: (2019) -
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE
por: Shen, Li, et al.
Publicado: (2021) -
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
por: Abdul-Rahim, Azmil H., et al.
Publicado: (2017) -
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox
por: Butt, Jawad H, et al.
Publicado: (2023) -
Drug therapy for heart failure with reduced ejection fraction: what is the ‘right’ dose?
por: Kondo, Toru, et al.
Publicado: (2022)